Urogenital Cancer Mortality in the Urology Department of CHU Gabriel Touré

Purpose: To study urogenital cancer mortality in the urology department of Gabriel Touré University Hospital.

Patients and Methods: This was a cross-sectional, retro-prospective, descriptive study spread over a 3-year period (January 2021 to December 2023).

Results: We recorded 37 deaths among 1077 hospitalized patients, equivalent to an overall mortality rate of 3.4%. Of these 37 deaths, 27 (72.9%) were due to urological cancer, representing a cancer mortality rate of 2.5%. The average age of the deceased patients was 57.70 years, ranging from 26 to 76 years. Among the study population, farmers predominated at 33.3%, followed closely by housewives at 29.6%. Hematuria was the most frequent reason for consultation at 48.1%, followed by back pain at 29.6%. In 92.5% of cases, death occurred before one month’s hospitalization, with 48.1% of deaths occurring before one week’s hospitalization. The only cancers to have led to death on the ward in the last three years were bladder cancer, prostate cancer and kidney cancer. Cancer mortality was dominated by bladder cancer at 66.7%, followed by prostate cancer at 22.2%. Among patients, 85.1% had severe anemia.

Conclusion: Bladder cancer emerges as the leading cause of mortality in the department. The majority of patients with cancer in the department die in associated contexts of anemia, renal failure and/or ionic disorders.

Keywords: Morality, Cancer, Urogenital.